Genome-wide association study reveals host genetic factors for liver diseases

Journal of Clinical and Translational Hepatology

Volumn 1, Issue 1, 2013, Pages 45-50

  Nishida, Nao ^a,b   Tokunaga, Katsushi ^b   Mizokami, Masashi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

GWAS; Hepatitis B infection; Hepatitis C infection; Hepatocellular carcinoma; HLA DP; Host genetic factors; Primary biliary cirrhosis

Indexed keywords

EID: 84947864372     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2013.010XX     Document Type: Article

References (42)

1. Collins FS, Mansoura MK. The Human Genome Project. Revealing the shared inheritance of all humankind. Cancer 2001;91:221–225.
2. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 2012;490:267–272.
3. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010;467:832–838.
4. Fujimoto A, Ohashi J, Nishida N, Miyagawa T, Morishita Y, Tsunoda T, et al. A replication study confirmed the EDAR gene to be a major contributor to population differentiation regarding head hair thickness in Asia. Hum Genet 2008;124:179–185.
5. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009;106:9362– 9367.
6. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009;41:1105–1109.
7. Nakamura M, Nishida N, Kawashima M, Aiba Y, Tanaka A, Yasunami M, et al. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet 2012;91:721–728.
8. Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, et al. No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. BMC Med Genet 2012;13:47.
9. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 59----39 exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276–7280.
10. Pourmand N, Elahi E, Davis RW, Ronaghi M. Multiplex pyrosequencing. Nucleic Acids Res 2002;30:e31.
11. Nishida N, Mawatari Y, Sageshima M, Tokunaga K. Highly parallel and shortacting amplification with locus-specific primers to detect single nucleotide polymorphisms by the DigiTag2 assay. PLoS One 2012;7:e29967.
12. Lindroos K, Liljedahl U, Raitio M, Syvanen AC. Minisequencing on oligonucleotide microarrays: comparison of immobilisation chemistries. Nucleic Acids Res 2001;29:E69–E69.
13. Bray MS, Boerwinkle E, Doris PA. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat 2001;17:296–304.
14. Nishida N, Koike A, Tajima A, Ogasawara Y, Ishibashi Y, Uehara Y, et al. Evaluating the performance of Affymetrix SNP Array 6.0 platform with 400 Japanese individuals. BMC Genomics 2008;9:431.
15. Shen R, Fan JB, Campbell D, Chang W, Chen J, Doucet D, et al. Highthroughput SNP genotyping on universal bead arrays. Mutat Res 2005;573: 70–82.
16. Kennedy GC, Matsuzaki H, Dong S, Liu WM, Huang J, Liu G, et al. Large-scale genotyping of complex DNA. Nat Biotechnol 2003;21:1233–1237.
17. Shrimpton AE, Levinsohn EM, Yozawitz JM, Packard DS Jr, Cady RB, Middleton FA, et al. AHOX gene mutation in a family with isolated congenital vertical talus and Charcot–Marie-Tooth disease. Am J Hum Genet 2004;75:92–96.
18. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650–654.
19. Kwiatkowski RW, Lyamichev V, de Arruda M, Neri B. Clinical, genetic, and pharmacogenetic applications of the Invader assay. Mol Diagn 1999;4:353– 364.
20. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y. A highthroughput SNP typing system for genome-wide association studies. J Hum Genet 2001;46:471–477.
21. Makridakis NM, Reichardt JK. Multiplex automated primer extension analysis: simultaneous genotyping of several polymorphisms. Biotechniques 2001;31:1374–1380.
22. Tang K, Fu DJ, Julien D, Braun A, Cantor CR, Köster H. Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci USA 1999;96:10016–10020.
23. Ohashi J, Tokunaga K. The power of genome-wide association studies of complex disease genes: statistical limitations of indirect approaches using SNP markers. J Hum Genet 2001;46:478–482.
24. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009;360: 2544–2555.
25. Hirschfield GM, Liu X, Han Y, Gorlov IP, Lu Y, Xu C, et al. Variants at IRF5TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 2010;42:655–657.
26. Liu X, Invernizzi P, Lu Y, Kosoy R, Lu Y, Bianchi I, et al. Genome-wide metaanalyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010;42:658–660.
27. Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, Shin SY, et al. Genomewide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 2011;43:329–332.
28. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004;127:485–492.
29. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009;461:399–401.
30. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009;41:1100–1104.
31. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010;138: 1338–1345, 1345.e1-e7.
32. Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010;42:755–758.
33. Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013;45:72–75.
34. Al-Qahtani A, Al-Anazi M, Viswan NA, Khalaf N, Abdo AA, Sanai FM, et al. Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis. PLoS One 2012;7:e45128.
35. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009;41:591–595.
36. Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, Hosono N, et al. A genomewide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 2011;20:3884–3892.
37. Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One 2012;7:e39175.
38. Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011;53:422–428.
39. An P, Winkler C, Guan L, O’Brien SJ, Zeng Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J Infect Dis 2011;203:943–947.
40. Vermehren J, Lötsch J, Susser S, Wicker S, Berger A, Zeuzem S, et al. A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. PLoS One 2012;7: e32605.
41. Li J, Yang D, He Y, Wang M, Wen Z, Liu L, et al. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case–control study. PLoS One 2011;6:e24221.
42. Barrett JC, Cardon LR. Evaluating coverage of genome-wide association studies. Nat Genet 2006;38:659–662.